179 related articles for article (PubMed ID: 16463759)
1. Psychosocial stress and cardiovascular disease Part 2: effectiveness of the Transcendental Meditation program in treatment and prevention.
Walton KG; Schneider RH; Nidich SI; Salerno JW; Nordstrom CK; Bairey Merz CN
Behav Med; 2002; 28(3):106-23. PubMed ID: 16463759
[TBL] [Abstract][Full Text] [Related]
2. Review of controlled research on the transcendental meditation program and cardiovascular disease. Risk factors, morbidity, and mortality.
Walton KG; Schneider RH; Nidich S
Cardiol Rev; 2004; 12(5):262-6. PubMed ID: 15316306
[TBL] [Abstract][Full Text] [Related]
3. Stress Reduction in the Prevention of Left Ventricular Hypertrophy: A Randomized Controlled Trial of Transcendental Meditation and Health Education in Hypertensive African Americans.
Schneider RH; Myers HF; Marwaha K; Rainforth MA; Salerno JW; Nidich SI; Gaylord-King C; Alexander CN; Norris KC
Ethn Dis; 2019; 29(4):577-586. PubMed ID: 31641325
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease prevention and health promotion with the transcendental meditation program and Maharishi consciousness-based health care.
Schneider RH; Walton KG; Salerno JW; Nidich SI
Ethn Dis; 2006; 16(3 Suppl 4):S4-15-26. PubMed ID: 16938913
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of stress reduction on mortality in persons > or = 55 years of age with systemic hypertension.
Schneider RH; Alexander CN; Staggers F; Rainforth M; Salerno JW; Hartz A; Arndt S; Barnes VA; Nidich SI
Am J Cardiol; 2005 May; 95(9):1060-4. PubMed ID: 15842971
[TBL] [Abstract][Full Text] [Related]
6. Stress reduction in the secondary prevention of cardiovascular disease: randomized, controlled trial of transcendental meditation and health education in Blacks.
Schneider RH; Grim CE; Rainforth MV; Kotchen T; Nidich SI; Gaylord-King C; Salerno JW; Kotchen JM; Alexander CN
Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):750-8. PubMed ID: 23149426
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial stress and cardiovascular disease. Part 3: Clinical and policy implications of research on the transcendental meditation program.
Walton KG; Schneider RH; Salerno JW; Nidich SI
Behav Med; 2005; 30(4):173-83. PubMed ID: 15981895
[TBL] [Abstract][Full Text] [Related]
8. Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis.
Rainforth MV; Schneider RH; Nidich SI; Gaylord-King C; Salerno JW; Anderson JW
Curr Hypertens Rep; 2007 Dec; 9(6):520-8. PubMed ID: 18350109
[TBL] [Abstract][Full Text] [Related]
9. Prevention and Treatment of Cardiovascular Disease in Adolescents and Adults through the Transcendental Meditation(®) Program: A Research Review Update.
Barnes VA; Orme-Johnson DW
Curr Hypertens Rev; 2012 Aug; 8(3):227-242. PubMed ID: 23204989
[TBL] [Abstract][Full Text] [Related]
10. Transcendental Meditation in the prevention and treatment of cardiovascular disease and pathophysiological mechanisms: An evidence-based review.
Schneider RH; Carr T
Adv Integr Med; 2014 Dec; 1(3):107-112. PubMed ID: 35813238
[TBL] [Abstract][Full Text] [Related]
11. Lowering cortisol and CVD risk in postmenopausal women: a pilot study using the Transcendental Meditation program.
Walton KG; Fields JZ; Levitsky DK; Harris DA; Pugh ND; Schneider RH
Ann N Y Acad Sci; 2004 Dec; 1032():211-5. PubMed ID: 15677413
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure response to transcendental meditation: a meta-analysis.
Anderson JW; Liu C; Kryscio RJ
Am J Hypertens; 2008 Mar; 21(3):310-6. PubMed ID: 18311126
[TBL] [Abstract][Full Text] [Related]
13. The impact of transcendental meditation on depressive symptoms and blood pressure in adults with cardiovascular disease: A systematic review and meta-analysis.
Gathright EC; Salmoirago-Blotcher E; DeCosta J; Balletto BL; Donahue ML; Feulner MM; Cruess DG; Wing RR; Carey MP; Scott-Sheldon LAJ
Complement Ther Med; 2019 Oct; 46():172-179. PubMed ID: 31519275
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial stress and cardiovascular disease: pathophysiological links.
Bairey Merz CN; Dwyer J; Nordstrom CK; Walton KG; Salerno JW; Schneider RH
Behav Med; 2002; 27(4):141-7. PubMed ID: 12165968
[TBL] [Abstract][Full Text] [Related]
15. Transcendental meditation, hypertension and heart disease.
King MS; Carr T; D'Cruz C
Aust Fam Physician; 2002 Feb; 31(2):164-8. PubMed ID: 11917830
[TBL] [Abstract][Full Text] [Related]
16. Yoga and meditation in cardiovascular disease.
Manchanda SC; Madan K
Clin Res Cardiol; 2014 Sep; 103(9):675-80. PubMed ID: 24464106
[TBL] [Abstract][Full Text] [Related]
17. A controlled study of the effects of the Transcendental Meditation program on cardiovascular reactivity and ambulatory blood pressure.
Wenneberg SR; Schneider RH; Walton KG; Maclean CR; Levitsky DK; Salerno JW; Wallace RK; Mandarino JV; Rainforth MV; Waziri R
Int J Neurosci; 1997 Jan; 89(1-2):15-28. PubMed ID: 9134445
[TBL] [Abstract][Full Text] [Related]
18. Childbearing, child-rearing, cardiovascular risk factors, and progression of carotid intima-media thickness: the Cardiovascular Risk in Young Finns study.
Skilton MR; Bonnet F; Begg LM; Juonala M; Kähönen M; Lehtimäki T; Viikari JS; Raitakari OT
Stroke; 2010 Jul; 41(7):1332-7. PubMed ID: 20538698
[TBL] [Abstract][Full Text] [Related]
19. Meditation can produce beneficial effects to prevent cardiovascular disease.
Koike MK; Cardoso R
Horm Mol Biol Clin Investig; 2014 Jun; 18(3):137-43. PubMed ID: 25390009
[TBL] [Abstract][Full Text] [Related]
20. Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association.
Levine GN; Lange RA; Bairey-Merz CN; Davidson RJ; Jamerson K; Mehta PK; Michos ED; Norris K; Ray IB; Saban KL; Shah T; Stein R; Smith SC;
J Am Heart Assoc; 2017 Sep; 6(10):. PubMed ID: 28963100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
